Top Story

CDC: Expansion of cancer screening requires more organized approach

May 5, 2015

The effectiveness of screening programs should lead to an expansion of cancer screening, albeit with more organization, surveillance and collaboration between health care systems and their communities, according to a CDC Grand Rounds report published in Morbidity and Mortality Weekly Report.

Because cancer remains the second leading cause of death in the United States, and 52% of cancer deaths are from cancers that can be identified earlier through current screening options, the CDC outlined uniform ways to improve screening access.

VIDEO: Updates in prostate cancer treatment options Meeting News CoverageVideo

VIDEO: Updates in prostate cancer treatment options

May 5, 2015
Robert S. DiPaola, MD, director of Rutgers Cancer Institute of New Jersey, discusses various forms of prostate cancer, along with the value of preventative care. DiPaola…
In the Journals

Leukemia patients at greater risk for C. difficile

May 5, 2015
Leukemia patients have a 2.6-fold higher risk for acquiring Clostridium difficile while in the hospital compared with the general population, according to a study…
Howard I. Scher, MD In the Journals

CTC, LDH biomarker panel serves as surrogate for prostate cancer survival

May 5, 2015
A biomarker panel composed of circulating tumor cell number and lactate dehydrogenase level accurately served as a surrogate for survival in men with…
Geena Wu Meeting News Coverage

Smoking criteria limits eligibility for lung cancer screening in NSCLC patients

May 5, 2015
SEATTLE — Less than one-third of patients with non-small cell lung cancer treated at a California medical center would have been eligible for lung cancer…
More News Headlines »
CME
Hematology Oncology Case Consults

Diagnosis and Management of Hemophilia

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of the patient with hemophilia supplemented with a case…
More »
Meeting News Coverage Video
VIDEO: Immunotherapies show promise in NSCLC, mesothelioma

VIDEO: Immunotherapies show promise in NSCLC, mesothelioma

May 1, 2015
PHILADELPHIA — Alex A. Adjei, MD, PhD, FACP, senior vice president of clinical research, professor and chair of…
More »
CME CNE
Low Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »
morganatic-roan